100
Participants
Start Date
June 20, 2012
Primary Completion Date
July 13, 2015
Study Completion Date
April 28, 2017
Rituximab
Participants received rituximab at the discretion of their treating physicians.
Weill Medical College of Cornell University; Hospital for Special Surgery, New York
University of Pittsburgh, Pittsburgh
University of Pennsylvania, Philadelphia
Johns Hopkins Asthma&Allergy, Baltimore
UNC- Chapel Hill, Chapel Hill
Duke Univ Medical Center, Durham
Mayo Clinic, Jacksonville
Cleveland Clinic Foundation, Cleveland
Mayo Clinic Rochester; Int.Med - Div. of Pul, Rochester
Rush University Medical Center, Chicago
University of Utah; Division of Rheumatology, Salt Lake City
Mayo Clinic Arizona, Scottsdale
Cedars-Sinai Medical Center, Los Angeles
Mass. General Hospital, Boston
Boston Medical Center, Boston
Lead Sponsor
Genentech, Inc.
INDUSTRY